Related coverage linked through entity extraction aliases.
May 06, 2026
St. Jude researchers linked specific childhood cancer therapies to DNA fingerprints in second neoplasms, potentially improving survivor surveillance and guiding safer treatments. Separately, the Global Platform for Access to Childhood Cancer Medicines has helped Nepal and Ghana build national cancer registries and implement national strategies.
May 11, 2026
A Nature Communications study reported that STING agonist 8803 inhibited tumor growth in human meningioma samples and reduced tumor volume and mortality in mouse models. Researchers found the STING pathway is expressed in both meningioma tumor cells and immune cells in the tumor microenvironment.
Feb 26, 2026
Northwestern Medicine researchers identified a potent immunotherapy approach targeting the STING pathway for meningiomas, the most common primary brain tumor. The experimental drug STING agonist 8803 triggered tumor cell death and immune responses in human samples and mouse models.
Feb 20, 2026
A study published in Science sequenced cancer-related genes in 493 cat tumor samples across 13 cancer types, revealing striking genetic similarities with human cancers and opening possibilities for shared treatments.
